The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design
Abstract
Recurrent S. aureus infections are common, suggesting that natural immune responses are not protective. All candidate vaccines tested thus far have failed to protect against S. aureus infections, highlighting an urgent need to better understand the mechanisms by which the bacterium interacts with the host immune system to evade or prevent protective immunity. Although there is evidence in murine models that both cellular and humoral immune responses are important for protection against S. aureus, human studies suggest that T cells are critical in determining susceptibility to infection. This review will use an “anatomic” approach to systematically outline the steps necessary in generating a T cell-mediated immune response against S. aureus. Through the processes of bacterial uptake by antigen presenting cells, processing and presentation of antigens to T cells, and differentiation and proliferation of memory and effector T cell subsets, the ability of S. aureus to evade or inhibit each step of the T-cell mediated response will be reviewed. We hypothesize that these interactions result in the redirection of immune responses away from protective antigens, thereby precluding the establishment of “natural” memory and potentially inhibiting the efficacy of vaccination. It is anticipated that this approach will reveal important implications for future design of vaccines to prevent these infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While Th17 cells and interleukin-17 (IL-17) are critical for protective immunity, S. aureus counteracts these defenses by modulating Toll-like receptor (TLR) signaling and producing superantigens [53,54].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [54]
In the citing paper
“While Th17 cells and interleukin-17 (IL-17) are critical for protective immunity, S. aureus counteracts these defenses by modulating Toll-like receptor (TLR) signaling and producing superantigens [53,54].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.009 · Cited by 1,004
Holland, S. M. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8136-z · Cited by 328
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Alonzo III, F., Kozhaya, L., Rawlings, S. A., Reyes-Robles, T., DuMont, A. L., Myszka, D. G., Landau, N. R., Unutmaz, D., & Torres, V. J. (2013) · Nature · doi:10.1038/nature11724 · Cited by 291
Ragle, B. E., & Bubeck Wardenburg, J. (2009) · Infection and Immunity · doi:10.1128/iai.00115-09 · Cited by 202
McNeely, T. B., Shah, N. A., Fridman, A., Joshi, A., Hartzel, J. S., Keshari, R. S., Lupu, F., & DiNubile, M. J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.34407 · Cited by 99
Research works printed but not linked: 107
- Sakr, 2018, Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections, Front Microbiol, 9, 2419, 10.3389/fmicb.2018.02419 · DOI · Paper page
- Kumar, 2015, High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department, J Clin Microbiol, 53, 810, 10.1128/JCM.03221-14 · DOI
- Fritz, 2013, A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection, Clin Infect Dis, 56, 1554, 10.1093/cid/cit123 · DOI
- Miller, 2015, Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors, Clin Infect Dis, 60, 753, 10.1093/cid/ciu943 · DOI
- Miller, 2020, Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS Microbiol Rev, 44, 123, 10.1093/femsre/fuz030 · DOI · Paper page
- Fowler, 2013, Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial, JAMA, 309, 1368, 10.1001/jama.2013.3010 · DOI · Paper page
- Gurtman, 2019, The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery, Hum Vaccin Immunother, 15, 358, 10.1080/21645515.2018.1523093 · DOI
- Verkaik, 2009, Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus, J Infect Dis, 199, 625, 10.1086/596743 · DOI · Paper page
- Blum, 2013, Pathways of antigen processing, Annu Rev Immunol, 31, 443, 10.1146/annurev-immunol-032712-095910 · DOI · Paper page
- Wieczorek, 2017, Major Histocompatibility Complex, Front Immunol, 8, 292, 10.3389/fimmu.2017.00292 · DOI · Paper page
- Hirosue, 2015, Modes of antigen presentation by lymph node stromal cells and their immunological implications, Front Immunol, 6, 446, 10.3389/fimmu.2015.00446 · DOI
- Pennock, 2013, T cell responses: naive to memory and everything in between, Adv Physiol Educ, 37, 273, 10.1152/advan.00066.2013 · DOI · Paper page
- Romani, 2010, Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin, Immunol Rev, 234, 120, 10.1111/j.0105-2896.2009.00886.x · DOI · Paper page
- Honold, 2018, Resident and monocyte-derived macrophages in cardiovascular disease, Circ Res, 122, 113, 10.1161/CIRCRESAHA.117.311071 · DOI · Paper page
- Gaudino, 2019, Cross-talk between antigen presenting cells and t cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis, Front Immunol, 10, 360, 10.3389/fimmu.2019.00360 · DOI · Paper page
- Sallusto, 2002, The instructive role of dendritic cells on T-cell responses, Arthritis Res, 10.1186/ar567 · DOI
- Thammavongsa, 2015, Staphylococcal manipulation of host immune responses, Nat Rev Microbiol, 13, 529, 10.1038/nrmicro3521 · DOI · Paper page
- Frucht, 2001, IFN-gamma production by antigen-presenting cells: mechanisms emerge, Trends Immunol, 22, 556, 10.1016/S1471-4906(01)02005-1 · DOI · Paper page
- Mutyambizi, 2009, The balance between immunity and tolerance: the role of Langerhans cells, Cell Mol Life Sci, 66, 831, 10.1007/s00018-008-8470-y · DOI
- Wu, 2014, Dendritic cells during Staphylococcus aureus infection: subsets and roles, J Transl Med, 12, 358, 10.1186/s12967-014-0358-z · DOI
- Coutant, 1999, Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen, Toxicol Sci, 52, 189, 10.1093/toxsci/52.2.189 · DOI
- Schindler, 2012, Dendritic cells are central coordinators of the host immune response to Staphylococcus aureus bloodstream infection, Am J Pathol, 181, 1327, 10.1016/j.ajpath.2012.06.039 · DOI
- Richardson, 2019, PSM Peptides from community-associated methicillin-resistant Staphylococcus aureus impair the adaptive immune response via modulation of dendritic cell subsets in vivo, Front Immunol, 10, 995, 10.3389/fimmu.2019.00995 · DOI
- Frodermann, 2011, A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus, J Infect Dis, 204, 253, 10.1093/infdis/jir276 · DOI
- Alonzo, 2014, The bicomponent pore-forming leucocidins of Staphylococcus aureus, Microbiol Mol Biol Rev, 78, 199, 10.1128/MMBR.00055-13 · DOI · Paper page
- Spaan, 2017, Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors, Nat Rev Microbiol, 15, 435, 10.1038/nrmicro.2017.27 · DOI · Paper page
- Yoong, 2013, The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond, Curr Opin Microbiol, 16, 63, 10.1016/j.mib.2013.01.012 · DOI
- Seilie, 2017, Staphylococcus aureus pore-forming toxins: the interface of pathogen and host complexity, Semin Cell Dev Biol, 72, 101, 10.1016/j.semcdb.2017.04.003 · DOI · Paper page
- Wilke, 2010, Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury, Proc Natl Acad Sci USA, 107, 13473, 10.1073/pnas.1001815107 · DOI · Paper page
- Becker, 2014, Tissue-specific patterning of host innate immune responses by Staphylococcus aureus alpha-toxin, J Innate Immun, 6, 619, 10.1159/000360006 · DOI
- Berube, 2013, Staphylococcus aureus alpha-toxin: nearly a century of intrigue, Toxins., 5, 1140, 10.3390/toxins5061140 · DOI · Paper page
- Lee, 2020, Staphylococcus aureus toxin suppresses antigen-specific T cell responses, J Clin Invest, 130, 1122, 10.1172/JCI130728 · DOI
- Sampedro, 2014, Targeting Staphylococcus aureus alpha-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections, J Infect Dis, 210, 1012, 10.1093/infdis/jiu223 · DOI
- Yang, 2020, Antibody-mediated protection against Staphylococcus aureus dermonecrosis: synergy of toxin neutralization and neutrophil recruitment, J Invest Dermatol, 10.1016/j.jid.2020.09.001 · DOI
- Akram, 2012, Immunodominance: a pivotal principle in host response to viral infections, Clin Immunol, 143, 99, 10.1016/j.clim.2012.01.015 · DOI
- Knight, 2020, Imprinting, immunodominance, and other impediments to generating broad influenza immunity, Immunol Rev, 296, 191, 10.1111/imr.12900 · DOI
- Dryla, 2005, Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients, Clin Diagn Lab Immunol, 12, 387, 10.1128/CDLI.12.3.387-398.2005 · DOI · Paper page
- Wu, 2018, Prevalence of IgG and neutralizing antibodies against Staphylococcus aureus alpha-toxin in healthy human subjects and diverse patient populations, Infect Immun, 86, e00671, 10.1128/IAI.00671-17 · DOI
- Hermos, 2010, High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection, Clin Infect Dis, 51, 1138, 10.1086/656742 · DOI
- Lorenz, 2000, Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus, FEMS Immunol Med Microbiol, 29, 145, 10.1111/j.1574-695X.2000.tb01517.x · DOI
- Koedijk, 2017, Differential epitope recognition in the immunodominant staphylococcal antigen A of Staphylococcus aureus by mouse versus human IgG antibodies, Sci Rep, 7, 8141, 10.1038/s41598-017-08182-9 · doi:10.1038/s41598-017-08182-9
- Thomsen, 2014, Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB, Infect Immun, 82, 1234, 10.1128/IAI.01558-13 · DOI
- Pelzek, 2018, Human memory B cells targeting Staphylococcus aureus exotoxins are prevalent with skin and soft tissue infection, mBio, 9, e02125, 10.1128/mBio.02125-17 · DOI
- Radke, 2018, Hierarchy of human IgG recognition within the Staphylococcus aureus immunome, Sci Rep, 8, 13296, 10.1038/s41598-018-31424-3 · DOI
- Soltan, 2020, Design of Staphylococcus aureus new vaccine candidates with B and T cell epitope mapping. reverse vaccinology, and immunoinformatics, OMICS, 24, 195, 10.1089/omi.2019.0183 · DOI
- Si, 2020, Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination, Sci Adv, 6, eaaw7713, 10.1126/sciadv.aaw7713 · DOI
- Nikcevich, 1994, Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo, J Immunol, 153, 1015, 10.4049/jimmunol.153.3.1015 · doi:10.4049/jimmunol.153.3.1015
- Yu, 2015, Identification of CD4+ T-cell epitopes on iron-regulated surface determinant B of Staphylococcus aureus, Microb Pathog, 89, 108, 10.1016/j.micpath.2015.09.006 · DOI
- Brown, 2015, Memory Th1 cells are protective in invasive Staphylococcus aureus infection, PLoS Pathog, 11, e1005226, 10.1371/journal.ppat.1005226 · DOI · Paper page
- Uebele, 2017, Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus, PLoS Pathog, 13, e1006387, 10.1371/journal.ppat.1006387 · DOI
- Kolata, 2015, The FALL OF A Dogma? Unexpected high T-cell memory response to Staphylococcus aureus in humans, J Infect Dis, 212, 830, 10.1093/infdis/jiv128 · DOI
- Oprea, 2013, Reverse-vaccinology strategy for designing T-cell epitope candidates for Staphylococcus aureus endocarditis vaccine, Biologicals, 41, 148, 10.1016/j.biologicals.2013.03.001 · DOI
- Monto, 2017, The doctrine of original antigenic sin: separating good from evil, J Infect Dis, 215, 1782, 10.1093/infdis/jix173 · DOI · Paper page
- Francis, 1960, On the doctrine of original antigenic sin, Proc. Am. Philosoph. Soc, 104, 572
- Kim, 2012, Strategies to alleviate original antigenic sin responses to influenza viruses, Proc Natl Acad Sci USA, 109, 13751, 10.1073/pnas.0912458109 · doi:10.1073/pnas.0912458109
- Pauli, 2014, Staphylococcus aureus infection induces protein A-mediated immune evasion in humans, J Exp Med, 211, 2331, 10.1084/jem.20141404 · DOI
- Henry, 2018, From original antigenic sin to the universal influenza virus vaccine, Trends Immunol, 39, 70, 10.1016/j.it.2017.08.003 · DOI · Paper page
- Blackwell, 2009, HLA and infectious diseases, Clin Microbiol Rev, 22, 370, 10.1128/CMR.00048-08 · DOI · Paper page
- DeLorenze, 2016, Polymorphisms in HLA class II genes are associated with susceptibility to Staphylococcus aureus infection in a white population, J Infect Dis, 213, 816, 10.1093/infdis/jiv483 · DOI
- Cyr, 2017, Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping, Genes Immun, 18, 95, 10.1038/gene.2017.6 · DOI
- Xu, 2012, Staphylococcal superantigens in colonization and disease, Front Cell Infect Microbiol, 2, 52, 10.3389/fcimb.2012.00052 · DOI · Paper page
- Krakauer, 2013, Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions, Toxins., 5, 1629, 10.3390/toxins5091629 · DOI
- Muller-Alouf, 2001, Superantigen bacterial toxins: state of the art, Toxicon, 39, 1691, 10.1016/S0041-0101(01)00156-8 · doi:10.1016/s0041-0101(01)00156-8
- Nizet, 2007, Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets, J Allergy Clin Immunol, 120, 13, 10.1016/j.jaci.2007.06.005 · DOI · Paper page
- Watson, 2012, Superantigen-induced CD4 memory T cell anergy. I. Staphylococcal enterotoxin B induces Fyn-mediated negative signaling, Cell Immunol, 276, 16, 10.1016/j.cellimm.2012.02.003 · DOI
- Lee, 2018, Induction of immunosuppressive CD8(+)CD25(+)FOXP3(+) regulatory T cells by suboptimal stimulation with staphylococcal enterotoxin C1, J Immunol, 200, 669, 10.4049/jimmunol.1602109 · DOI
- Venkatasubramaniam, 2019, TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens, Sci Rep, 9, 3279, 10.1038/s41598-019-39890-z · DOI
- Gampfer, 2002, Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome, Vaccine, 20, 1354, 10.1016/S0264-410X(01)00470-4 · doi:10.1016/s0264-410x(01)00470-4
- Hu, 2003, Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection, J Infect Dis, 188, 743, 10.1086/377308 · DOI
- Weinreich, 2011, Postselection thymocyte maturation and emigration are independent of IL-7 and ERK5, J Immunol, 186, 1343, 10.4049/jimmunol.1002238 · DOI
- Ng, 2010, Role of secondary lymphoid tissues in primary and memory T-cell responses to a transplanted organ, Transplant Rev., 24, 32, 10.1016/j.trre.2009.09.003 · DOI
- Bonelli, 2014, Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes, Curr Top Microbiol Immunol, 381, 279, 10.1007/82_2014_371 · DOI
- Zhu, 2010, Differentiation of effector CD4 T cell populations, Annu Rev Immunol, 28, 445, 10.1146/annurev-immunol-030409-101212 · DOI · Paper page
- Hampton, 2019, Lymphatic migration of immune cells, Front Immunol, 10, 1168, 10.3389/fimmu.2019.01168 · DOI · Paper page
- Broker, 2016, The T cell response to Staphylococcus aureus, Pathogens, 5, 31, 10.3390/pathogens5010031 · DOI
- Miller, 2011, Immunity against Staphylococcus aureus cutaneous infections, Nat Rev Immunol, 11, 505, 10.1038/nri3010 · DOI · Paper page
- Ge, 2020, Biology of interleukin-17 and its pathophysiological significance in sepsis, Front Immunol, 11, 1558, 10.3389/fimmu.2020.01558 · DOI · Paper page
- Renner, 2008, Identification of a 27 kDa protein in patients with anaphylactic reactions to mango, J Investig Allergol Clin Immunol, 18, 476
- Dellinger, 2008, Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008, Crit Care Med, 36, 296, 10.1097/01.CCM.0000298158.12101.41 · DOI · Paper page
- Hidron, 2010, Methicillin-resistant Staphylococcus aureus in HIV-infected patients, Infect Drug Resist, 3, 73, 10.2147/IDR.S7641 · DOI
- Reiss-Mandel, 2018, Staphylococcus aureus colonization induces strain-specific suppression of interleukin-17, Infect Immun, 86, e00834, 10.1128/IAI.00834-17 · DOI
- Cho, 2010, IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice, J Clin Invest, 120, 1762, 10.1172/JCI40891 · DOI · Paper page
- Montgomery, 2014, Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A, Infect Immun, 82, 2125, 10.1128/IAI.01491-14 · DOI
- Karauzum, 2017, Lethal CD4 T cell responses induced by vaccination against Staphylococcus aureus bacteremia, J Infect Dis, 215, 1231, 10.1093/infdis/jix096 · DOI
- Kim, 2019, Interactions between atopic dermatitis and staphylococcus aureus infection: clinical implications, Allergy Asthma Immunol Res, 11, 593, 10.4168/aair.2019.11.5.593 · DOI · Paper page
- Aujla, 2008, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia, Nat Med, 14, 275, 10.1038/nm1710 · DOI · Paper page
- Cheng, 2012, Role of gamma-delta T cells in host response against Staphylococcus aureus-induced pneumonia, BMC Immunol, 13, 38, 10.1186/1471-2172-13-38 · DOI
- Cooper, 2020, Activation of human Vdelta2(+) gammadelta T Cells by Staphylococcus aureus promotes enhanced anti-staphylococcal adaptive immunity, J Immunol, 205, 1039, 10.4049/jimmunol.2000143 · DOI
- Nygaard, 2012, Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection, PLoS ONE, 7, e36532, 10.1371/journal.pone.0036532 · DOI
- Bonifacius, 2020, Staphylococcus aureus Alpha-toxin limits type 1 while fostering type 3 immune responses, Front Immunol, 11, 1579, 10.3389/fimmu.2020.01579 · DOI
- Leech, 2019, Toxin-triggered interleukin-1 receptor signaling enables early-life discrimination of pathogenic versus commensal skin bacteria, Cell Host Microbe, 26, 795, 10.1016/j.chom.2019.10.007 · DOI
- Kaesler, 2016, Staphylococcus aureus-derived lipoteichoic acid induces temporary T-cell paralysis independent of Toll-like receptor 2, J Allergy Clin Immunol, 138, 780, 10.1016/j.jaci.2015.11.043 · DOI
- Sanchez, 2017, O-acetylation of peptidoglycan limits helper T cell priming and permits Staphylococcus aureus reinfection, Cell Host Microbe, 10.1016/j.chom.2017.08.008 · DOI
- Orfali, 2019, Staphylococcal enterotoxins modulate the effector CD4(+) T cell response by reshaping the gene expression profile in adults with atopic dermatitis, Sci Rep, 9, 13082, 10.1038/s41598-019-49421-5 · DOI
- Tebartz, 2015, A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection, J Immunol, 194, 1100, 10.4049/jimmunol.1400196 · DOI
- Tong, 2015, Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management, Clin Microbiol Rev, 28, 603, 10.1128/CMR.00134-14 · DOI · Paper page
- Redi, 2018, Staphylococcus aureus vaccine preclinical and clinical development: current state of the art, New Microbiol, 41, 208
- Fattom, 2004, Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine. (StaphVAX) in hemodialysis patients, Vaccine, 23, 656, 10.1016/j.vaccine.2004.06.043 · DOI
- Frenck, 2017, Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine. (SA4Ag): results from a first-in-human randomised, placebo-controlled phase 1/2 study, Vaccine, 35, 375, 10.1016/j.vaccine.2016.11.010 · DOI
- Proctor, 2012, Challenges for a universal Staphylococcus aureus vaccine, Clin Infect Dis, 54, 1179, 10.1093/cid/cis033 · DOI · Paper page
- Oscherwitz, 2015, Identification and validation of a linear protective neutralizing epitope in the beta-pore domain of alpha toxin, PLoS ONE, 10, e0116882, 10.1371/journal.pone.0116882 · DOI
- Salgado-Pabon, 2014, Staphylococcus aureus beta-toxin production is common in strains with the beta-toxin gene inactivated by bacteriophage, J Infect Dis, 210, 784, 10.1093/infdis/jiu146 · DOI
- Kim, 2014, Mouse models for infectious diseases caused by Staphylococcus aureus, J Immunol Methods, 410, 88, 10.1016/j.jim.2014.04.007 · DOI · Paper page
- Bagnoli, 2015, Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus, Proc Natl Acad Sci USA, 112, 3680, 10.1073/pnas.1424924112 · DOI · Paper page
- Monaci, 2015, MF59- and Al(OH)3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers, Front Immunol, 6, 439, 10.3389/fimmu.2015.00439 · DOI
- Proctor, 2015, Recent developments for Staphylococcus aureus vaccines: clinical and basic science challenges, Eur Cell Mater, 30, 315, 10.22203/eCM.v030a22 · DOI
- Engelman, 2014, Invasive Staphylococcus aureus infections in children in tropical Northern Australia, J Pediatric Infect Dis Soc, 3, 304, 10.1093/jpids/piu013 · DOI
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Teymournejad, O., & Montgomery, C. P.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-22
- Volume
- 12
- ISSN
- 1664-3224
- Cited by
- 30
- References
- 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design. https://app.cochat.ai/papers/10.3389/fimmu.2021.633672
- The paper
- Teymournejad, O., & Montgomery, C. P. (2021). Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.633672
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.